Forest Laboratories is close to an agreement to buy New Jersey-based specialty pharmaceutical company Aptalis Holdings from private equity firm TPG Capital. Forest will pay $3 billion for Aptalis.
Aptalis Holdings Inc
Breaking News
A filing with the US Securities and Exchange Commission revealed that Aptalis Holdings Inc has plans to conduct a share sale on the Nasdaq Stock Market and raise up to $500 million in the process.
